Celldex Therapeutics reported $0 in Loan Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US $ 35705M 305M
Applied Genetic Technologies AGTC:US $ 11.36M 2.18M
Biocept BIOC:US $ 1.22M 0.21M
Bristol Myers Squibb BMY:US $ 37107M 343M
Celldex Therapeutics CLDX:US $ 0M 0M
Cytrx CYTR:US 0 0
Glaxosmithkline GSK:US $ 18784M 10442M
Merrimack Pharmaceuticals MACK:US $ 0 0
Nektar Therapeutics NKTR:US $ 0M 0M
Newlink Genetics NLNK:US $ 0M 0M
Northwest Biotherapeutics NWBO:US 16.16M 8.99M
Seattle Genetics SGEN:US $ 0M 0M